InsidersTradesSigma
Follow the IX BIOPHARMA LTD. stock price and the full directors' dealings record of the company, a listed issuer based in Singapore. Shares are listed on the SG market, under the oversight of SGX. Market capitalisation: €442.8m. The latest transaction was reported on 26 July 2026 (Purchase). Among the most active insiders: Oversea-Chinese Banking Corporation Limited. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
IX Biopharma Ltd. is a company focused on developing pharmaceutical treatments, emphasizing research and innovation in the biopharmaceutical field.